Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misotac vs COCP for Symptomatic Isthmocele
NCT04579965Unknown
- Sponsor
- Mansoura University Hospital
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
Randomised trial of Misotac in cesarean scar defect (CSD) (2 arms), sponsored by Mansoura University Hospital. Primary endpoint: postmenstrual spotting at 1 month. Status: unknown.
02
Drugs
Misotac
03
Conditions
cesarean scar defect (CSD)
Beyond the preview
Go deeper on NCT04579965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04579965.